275 related articles for article (PubMed ID: 16946499)
1. Inhibitory effects of Korean red ginseng and its genuine constituents ginsenosides Rg3, Rf, and Rh2 in mouse passive cutaneous anaphylaxis reaction and contact dermatitis models.
Bae EA; Han MJ; Shin YW; Kim DH
Biol Pharm Bull; 2006 Sep; 29(9):1862-7. PubMed ID: 16946499
[TBL] [Abstract][Full Text] [Related]
2. Effects of topically applied Korean red ginseng and its genuine constituents on atopic dermatitis-like skin lesions in NC/Nga mice.
Kim HS; Kim DH; Kim BK; Yoon SK; Kim MH; Lee JY; Kim HO; Park YM
Int Immunopharmacol; 2011 Feb; 11(2):280-5. PubMed ID: 21118672
[TBL] [Abstract][Full Text] [Related]
3. Effect of ginsenoside Rb1 and compound K in chronic oxazolone-induced mouse dermatitis.
Shin YW; Bae EA; Kim SS; Lee YC; Kim DH
Int Immunopharmacol; 2005 Jul; 5(7-8):1183-91. PubMed ID: 15914323
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of antipruritic effects of red ginseng and its ingredients in mice.
Trinh HT; Shin YW; Han SJ; Han MJ; Kim DH
Planta Med; 2008 Feb; 74(3):210-4. PubMed ID: 18300192
[TBL] [Abstract][Full Text] [Related]
5. Antiallergic activity of ginsenoside Rh2.
Park EK; Choo MK; Kim EJ; Han MJ; Kim DH
Biol Pharm Bull; 2003 Nov; 26(11):1581-4. PubMed ID: 14600405
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory effect of ginsenoside Rg5 and its metabolite ginsenoside Rh3 in an oxazolone-induced mouse chronic dermatitis model.
Shin YW; Bae EA; Kim DH
Arch Pharm Res; 2006 Aug; 29(8):685-90. PubMed ID: 16964764
[TBL] [Abstract][Full Text] [Related]
7. Anxiolytic-like effects of ginsenosides Rg3 and Rh2 from red ginseng in the elevated plus-maze model.
Kim TW; Choi HJ; Kim NJ; Kim DH
Planta Med; 2009 Jun; 75(8):836-9. PubMed ID: 19266429
[TBL] [Abstract][Full Text] [Related]
8. Generation of ginsenosides Rg3 and Rh2 from North American ginseng.
Popovich DG; Kitts DD
Phytochemistry; 2004 Feb; 65(3):337-44. PubMed ID: 14751305
[TBL] [Abstract][Full Text] [Related]
9. Red American ginseng: ginsenoside constituents and antiproliferative activities of heat-processed Panax quinquefolius roots.
Wang CZ; Aung HH; Ni M; Wu JA; Tong R; Wicks S; He TC; Yuan CS
Planta Med; 2007 Jun; 73(7):669-74. PubMed ID: 17538869
[TBL] [Abstract][Full Text] [Related]
10. Ginsenoside Rh1 possesses antiallergic and anti-inflammatory activities.
Park EK; Choo MK; Han MJ; Kim DH
Int Arch Allergy Immunol; 2004 Feb; 133(2):113-20. PubMed ID: 14739579
[TBL] [Abstract][Full Text] [Related]
11. Ginsenoside Rh2 reduces ischemic brain injury in rats.
Park EK; Choo MK; Oh JK; Ryu JH; Kim DH
Biol Pharm Bull; 2004 Mar; 27(3):433-6. PubMed ID: 14993818
[TBL] [Abstract][Full Text] [Related]
12. The effects of ginsenoside Re and its metabolite, ginsenoside Rh1, on 12-O-tetradecanoylphorbol 13-acetate- and oxazolone-induced mouse dermatitis models.
Shin YW; Bae EA; Kim SS; Lee YC; Lee BY; Kim DH
Planta Med; 2006 Mar; 72(4):376-8. PubMed ID: 16557482
[TBL] [Abstract][Full Text] [Related]
13. Neuroprotective Effects of Ginsenosides against Cerebral Ischemia.
Cheng Z; Zhang M; Ling C; Zhu Y; Ren H; Hong C; Qin J; Liu T; Wang J
Molecules; 2019 Mar; 24(6):. PubMed ID: 30897756
[TBL] [Abstract][Full Text] [Related]
14. Ginsenoside Rh2 ameliorates scopolamine-induced learning deficit in mice.
Yang JH; Han SJ; Ryu JH; Jang IS; Kim DH
Biol Pharm Bull; 2009 Oct; 32(10):1710-5. PubMed ID: 19801832
[TBL] [Abstract][Full Text] [Related]
15. Bifidus fermentation increases hypolipidemic and hypoglycemic effects of red ginseng.
Trinh HT; Han SJ; Kim SW; Lee YC; Kim DH
J Microbiol Biotechnol; 2007 Jul; 17(7):1127-33. PubMed ID: 18051323
[TBL] [Abstract][Full Text] [Related]
16. Production of Rare Ginsenosides Rg3 and Rh2 by Endophytic Bacteria from
Yan H; Jin H; Fu Y; Yin Z; Yin C
J Agric Food Chem; 2019 Aug; 67(31):8493-8499. PubMed ID: 31310523
[TBL] [Abstract][Full Text] [Related]
17. Fermentation-Mediated Enhancement of Ginseng's Anti-Allergic Activity against IgE-Mediated Passive Cutaneous Anaphylaxis In Vivo and In Vitro.
Hwang SW; Sun X; Han JH; Kim TY; Koppula S; Kang TB; Hwang JK; Lee KH
J Microbiol Biotechnol; 2018 Oct; 28(10):1626-1634. PubMed ID: 30178651
[TBL] [Abstract][Full Text] [Related]
18. Ginsenoside Rg3 attenuates microglia activation following systemic lipopolysaccharide treatment in mice.
Park SM; Choi MS; Sohn NW; Shin JW
Biol Pharm Bull; 2012; 35(9):1546-52. PubMed ID: 22975507
[TBL] [Abstract][Full Text] [Related]
19. Ginsenosides Rg3 and Rh2 inhibit the activation of AP-1 and protein kinase A pathway in lipopolysaccharide/interferon-gamma-stimulated BV-2 microglial cells.
Bae EA; Kim EJ; Park JS; Kim HS; Ryu JH; Kim DH
Planta Med; 2006 Jun; 72(7):627-33. PubMed ID: 16673329
[TBL] [Abstract][Full Text] [Related]
20. Transformation of ginseng saponins to ginsenoside Rh2 by acids and human intestinal bacteria and biological activities of their transformants.
Bae EA; Han MJ; Kim EJ; Kim DH
Arch Pharm Res; 2004 Jan; 27(1):61-7. PubMed ID: 14969341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]